Who We Are
Who We Are
“We wholeheartedly believe that no rare disease is too rare to prevent us from trying to develop a therapy for”
“We wholeheartedly believe that no rare disease is too rare to prevent us from trying to develop a therapy for”
Based in California with global clientele, our team of experts and consultants are committed to providing highly-specialized scientific consultancy and genomic advisory services to pharmaceuticals, biotechs, molecular diagnostic labs, academics, healthcare systems and non-profit organizations.
Based in California with global clientele, our team of experts and consultants are committed to providing highly-specialized scientific consultancy and genomic advisory services to pharmaceuticals, biotechs, molecular diagnostic labs, academics, healthcare systems and non-profit organizations.
Our founder Dr. Qais Abu Ali (MD, FACMG), is an American-board certified physician and geneticist, whose track record in leadership and successful global clinical trial design and conduct has culminated in multiple drug approvals for ultra-rare genetic diseases in the US, EU and other regions of the world.
Our founder Dr. Qais Abu Ali (MD, FACMG), is an American-board certified physician and geneticist, whose track record in leadership and successful global clinical trial design and conduct has culminated in multiple drug approvals for ultra-rare genetic diseases in the US, EU and other regions of the world.
Our mission is our commitment to help advance therapeutics and diagnostics for rare genetic diseases globally.
Our mission is our commitment to help advance therapeutics and diagnostics for rare genetic diseases globally.
Meet the Team
Meet the Team
Qais Abu Ali, MD, FACMG
Qais Abu Ali, MD, FACMG
Founder
Founder
Chief Genomics and Medical Officer
Chief Genomics and Medical Officer